1. To evaluate study on effect of Canagliflozin on Renal and Cardiovascular outcomes across different levels of Albuminuria.
2. To determine clinical significance of study results.
11/21/2019 - 1:00pm to 2:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. Samantha Gunning